Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19330033.
- Also identified by DOI 10.1371/journal.pone.0005005 and PMC identifier 2658887.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Fibrodysplasia Ossificans Progressiva (FOP) is a rare, heritable condition typified by progression of extensive ossification within skeletal muscle, ligament and tendon together with defects in skeletal development. The condition is easily diagnosed by the presence of shortened great toes and there is severe advancement of disability with age. FOP has been shown to result from a point mutation (c.617G>A) in the ACVR1 gene in almost all patients reported. Very recently two other mutations have been described in three FOP patients. We present here evidence for two further unique mutations (c.605G>T and c.983G>A) in this gene in two FOP patients with some atypical digit abnormalities and other clinical features. The observation of disparate missense mutations mapped to the GS and kinase domains of the protein supports the disease model of mild kinase activation and provides a potential rationale for phenotypic variation.
Medical subject headings
- Activin Receptors, Type I
- Myositis Ossificans
- Point Mutation